Market Access Tracker
Timely Insights into a Fast-Changing Environment
Market access is increasingly critical to a drug’s commercial success, but it’s a challenge as payers are increasing prelaunch and post-marketing obstacles and the market access environment is in constant flux. Decision Resources’ Market Access Tracker service explains the challenges and opportunities to gaining—and maintaining—favorable market access terms. Included in the analysis:
- How healthcare systems operate
- Who the key decision makers are in each country
- What procedures govern price setting and admission to reimbursement
- Which are the key factors that influence market access
- What cost-containment pressures marketers will face after launch
Timely analysis of key events, regular webinar update presentations and access to our team of experts will equip biopharmaceutical companies with the insight needed to evaluate the implications of the latest changes for their business and to assess the commercial outlook in each market.
Geographic services include:
Americas: United States, Canada, Mexico, Brazil, Argentina
Europe: France, Germany, Italy, Spain, United Kingdom, Russia, Turkey
Asia-Pacific: Japan, China, India, South Korea, Australia
Global: all 17 countries
Key benefits:
- Three international regions comprising 17 countries
- Evergreen, rapid updates
- Event-driven analysis of the market access environment
- In-depth, web-based country profiles
- Concise national overviews in PowerPoint format